Jones Financial Companies’s Dynavax Technologies DVAX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-3,201
Closed -$49.2K 4782
2025
Q4
$49.2K Buy
3,201
+640
+25% +$7.05K ﹤0.01% 2535
2025
Q3
$25K Buy
2,561
+400
+19% +$4.16K ﹤0.01% 2680
2025
Q2
$21.4K Hold
2,161
﹤0.01% 2561
2025
Q1
$29.6K Buy
2,161
+1,525
+240% +$20.2K ﹤0.01% 2282
2024
Q4
$8.12K Hold
636
﹤0.01% 2600
2024
Q3
$7K Hold
636
﹤0.01% 2348
2024
Q2
$7.14K Buy
+636
New +$7.4K ﹤0.01% 1860

Other funds holding DVAX

Jones Financial Companies's DVAX Position: Q1 2026 in Review

Jones Financial Companies sold out of Dynavax Technologies (DVAX) in Q1 2026, closing a stake of 3,201 shares — an estimated $49.2K sold.

Jones Financial Companies first reported a position in DVAX in Q2 2024 and held it in 7 quarters. The position peaked at $49.2K in Q4 2025. 1 fund tracked by Wall St. Rank holds DVAX as of Q1 2026.

  • Jones Financial Companies reported no remaining Dynavax Technologies position as of Q1 2026 after selling out during the quarter.
  • Jones Financial Companies sold 3,201 Dynavax Technologies shares in Q1 2026, an estimated $49.2K.
  • Jones Financial Companies first reported a position in Dynavax Technologies in Q2 2024 and held it in 7 quarters.
  • Jones Financial Companies's Dynavax Technologies position peaked at $49.2K in Q4 2025.
  • 1 fund tracked by Wall St. Rank held Dynavax Technologies as of Q1 2026.

Based on Jones Financial Companies's 13F filing for Q1 2026, filed 15 May 2026.